إعلان
إعلان
HBIO
Harvard Bioscience Inc
0.67
USDبرعاية
-0.02
-2.53%
٠٧ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
0.68
0.00
+0.69%
تقارير أرباح HBIO
النسبة الإيجابية المفاجئة
HBIO تفوق 15 من 40 آخر التقديرات.
38%
التقرير التالي
بيانات التقرير القادم
١٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$23.56M
/$0.03
التغير الضمني من Q3 25 (Revenue/ EPS)
+14.43%
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
-4.05%
/-50.00%
Harvard Bioscience Inc earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, HBIO reported earnings of 0.00 USD per share (EPS) for Q3 25, missing the estimate of 0.00 USD, resulting in a -100.00% surprise. Revenue reached 20.59 مليون, compared to an expected 20.40 مليون, with a 0.94% difference. The market reacted with a -7.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of 0.03 USD, with revenue projected to reach 23.56 مليون USD, implying an -- of --% EPS, and زيادة of 14.43% in Revenue from the last quarter.
الأسئلة الشائعة
What were Harvard Bioscience Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Harvard Bioscience Inc reported EPS of $0.00, missing estimates by -100%, and revenue of $20.59M, 0.94% above expectations.
How did the market react to Harvard Bioscience Inc's Q3 2025 earnings?
The stock price moved down -7.29%, changed from $0.59 before the earnings release to $0.55 the day after.
When is Harvard Bioscience Inc expected to report next?
The next earning report is scheduled for ١٠ مارس ٢٠٢٦.
What are the forecasts for Harvard Bioscience Inc's next earnings report?
Based on 4
المحللين, Harvard Bioscience Inc is expected to report EPS of $0.03 and revenue of $23.56M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان